Exhibit 10.28.4
REDACTED VERSION
*** Confidential treatment has been requested as to certain portions of
this agreement. Such omitted confidential information has been designated
by an asterisk and has been filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange
Act of 1934, as amended, and the Commission's rules and regulations
promulgated under the Freedom of Information Act, pursuant to a request
for confidential treatment.***
[GRIFOLS LETTERHEAD]
Attention: Fax Number: Date:
Xx. Xxxxx Xxxxx (000) 000-0000 November 7, 2000
Cc:
Xxxxxx Grifols, Xxxxxx Xxxxx
From:
Xxxxx Xxxxx Subject: Your fax of November 6, 2000
Dear Xxxxx:
I acknowledge receipt with thanks of your fax of November 06 in which you
state your final offer for *** liters of plasma for calendar year 2001 at
USDL. ***/liter.
In this regard, I confirm that we have decided to accept your quotation
although it involves an important increase in costs and furthermore the
current exchange rate between USDL. and euro entails an unfavourable
situation. Nevertheless, we appreciate your efforts and understand that your
final proposal is reasonable under the current circumstances and, therefore,
acceptable.
On the other hand, we assume that further discussions concerning additional
quantities of plasma are postponed.
Finally, we would like to thank you for your continued willingness and
collaboration.
Best regards,
GRUPO GRIFOLS, S.A.
/s/ Xxxxx Xxxxx
---------------------------
Vice-President
Sales & Marketing
-----------------------------------
*** Confidential information omitted and filed separately with the Securities
and Exchange Commission.
